Lainie P. Martin - Publications, H-index & Citations

Lainie P. Martin

university of pennsylvania

40H指数

276论文数

7.2K被引数

收录论文 35

发表时间

Rucaparib maintenance for newly diagnosed advanced ovarian cancer: interim overall survival, progression-free survival, and safety at 5 years of follow-up from the phase III ATHENA-MONO/GOG-3020/ENGOT-ov45 鲁卡帕利用于新诊断晚期卵巢癌的维持治疗：来自III期ATHENA-MONO/GOG-3020/ENGOT-ov45研究5年随访的 interim 总体生存期、无进展生存期及安全性数据

Annals of Oncology

IF65.4

2025-10-18

OAAI

R.S. Kristeleit; S. Ghamande; A. Lisyanskaya; A. Oaknin; E. Prendergast; Y.B. Kim; J.Fuentes Pradera; R.D. Littell; B. Gao; G. Valabrega; D.M. O’Malley; A. Dean; C. Pisano; J. Buscema; D. Provencher; F. Zagouri; L.P. Martin; H.-H. Chou; F. Demirkiran; F. Ueland; A. Chudecka-Głaz; O. Yeku; M. Beiner; C. Anderson; V. Drochytek; R.N. Eskander; R. Agarwal; L. Maloney; D. Despain; C. Connor; M. Craib; D. Shih; K. Fujiwara; B.J. Monk

Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)–targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancer mirvetuximab soravtansine（一种靶向叶酸受体α（FRα）的抗体偶联药物，ADC）与pembrolizumab联合治疗铂耐药性卵巢癌患者的安全性与有效性

gynecologic oncology

IF4.1

2025-07-22

PREAI

Ursula A. Matulonis; Ignace Vergote; Kathleen N. Moore; Lainie P. Martin; Cesar M. Castro; Lucy Gilbert; Yu Xia; Michael Method; James Stec; Michael J. Birrer; David M. O'Malley

A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer 一项关于rucaparib与安慰剂在转移性和复发性子宫内膜癌维持治疗中使用的II期、随机、双盲研究

gynecologic oncology

IF4.1

2025-07-22

PREAI

Bradley R. Corr; Ashley Haggerty; Stefan M. Gysler; Sarah Taylor; Kian Behbakht; Jill Alldredge; Carolyn Lefkowits; Lindsay W. Brubaker; Catherine Bouts; Lisa Marie Babayan; Lainie P. Martin; James Costello; Benjamin G. Bitler; Junxiao Hu; Saketh R. Guntupalli

Real-world impact of the platinum chemotherapy shortage on US patients with advanced cancer

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2024-12-03

PREAI

Reibel, Jacob B.; Sun, Lova L.; Parikh, Ravi B.; Mahmud, Nadim; Martin, Lainie P.; Hubbard, Rebecca A.; Mamtani, Ronac

Ovarian Cancer/Fallopian Tube Cancer/Primary PeritonealCancer, Version 3.2024Featured Updates to the NCCN Guidelines 卵巢癌/输卵管癌/原发性腹膜癌，版本3.2024 NCCN指南重点更新

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2024-10-01

PREAI

Liu, Joyce; Berchuck, Andrew; Backes, Floor J.; Cohen, Joshua; Grisham, Rachel; Leath, Charles A., III; Martin, Lainie; Matei, Daniela; Miller, David S.; Robertson, Sharon; Barroilhet, Lisa; Uppal, Shitanshu; Hendrickson, Andrea Wahner; Gershenson, David M.; Gray, Heidi J.; Hakam, Ardeshir; Jain, Angela; Konecny, Gottfried E.; Moroney, John; Ratner, Elena; Schorge, John; Thaker, Premal H.; Werner, Theresa L.; Zsiros, Emese; Behbakht, Kian; Chen, Lee-May; Derosa, Marie; Eisenhauer, Eric L.; Leiserowitz, Gary; Litkouhi, Babak; Mchale, Michael; Percac-Lima, Sanja; Rodabaugh, Kerry; Vargas, Roberto; Jones, Frankie; Kovach, Emily; Hang, Lisa; Ramakrishnan, Swathi; Alvarez, Ronald D.; Armstrong, Deborah K.

Luveltamab tazevibulin, an antifolate receptor alpha (FRa) antibody-drug conjugate (ADC), in combination with bevacizumab (bev) in patients with recurrent high-grade epithelial ovarian cancer (EOC): STRO-002-GM2 phase I study Luveltamab tazevibulin，一种抗叶酸受体α（FRa）抗体药物偶联物（ADC），与贝伐珠单抗（bev）联用治疗复发性高级别上皮性卵巢癌（EOC）患者：STRO-002-GM2 Ⅰ期研究

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Martin, L. P.; Uyar, D.; Madariaga, A.; Spira, A. I.; Oaknin, A.; Schilder, R.; Alia, E. M. Guerra; Hamilton, E. P.; Naumann, R. W.; Lorusso, D.; Lu, L.; Berman, C. J.; Borgman, A. E.; Moroney, J. W.

Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer Mirvetuximab Soravtansine在fr α 阳性，铂类耐药卵巢癌中的应用

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2023-12-07

OAAI

Moore, K. N.; Angelergues, A.; Konecny, G. E.; Garcia, Y.; Banerjee, S.; Lorusso, D.; Lee, J. -Y.; Moroney, J. W.; Colombo, N.; Roszak, A.; Tromp, J.; Myers, T.; Lee, J. -W.; Beiner, M.; Cosgrove, C. M.; Cibula, D.; Martin, L. P.; Sabatier, R.; Buscema, J.; Estevez-Garcia, P.; Coffman, L.; Nicum, S.; Duska, L. R.; Pignata, S.; Galvez, F.; Wang, Y.; Method, M.; Berkenblit, A.; Roufai, D. Bello; Van Gorp, T.

Luveltamab tazevibulin (STRO-002), an anti-folate receptor alpha (FolRa) antibody drug conjugate (ADC), demonstrates clinical activity in recurrent/progressive epithelial endometrial cancer (EEC): STRO-002-GM1 phase I dose expansion

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

OAAI

Pothuri, B.; Naumann, R. W.; Martin, L. P.; O'Malley, D.; Uyar, D.; Moroney, J. W.; Diaz, J.; Garcia-Donas, J.; Sanchez, A. Redondo; Martin, A. Gonzalez; Illescas, D. G.; Liu, L.; Berman, C.; Oaknin, A.

A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors

NATURE COMMUNICATIONS

IF15.7

2023-07-27

OAAI

Zibelman, Matthew; MacFarlane, Alexander W.; Costello, Kimberly; McGowan, Thomas; O'Neill, John; Kokate, Rutika; Borghaei, Hossein; Denlinger, Crystal S.; Dotan, Efrat; Geynisman, Daniel M.; Jain, Angela; Martin, Lainie; Obeid, Elias; Devarajan, Karthik; Ruth, Karen; Alpaugh, R. Katherine; Dulaimi, Essel Al-Saleem; Cukierman, Edna; Einarson, Margret; Campbell, Kerry S.; Plimack, Elizabeth R.

Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor- Resistant Homologous Recombination-Deficient Ovarian Cancer

CLINICAL CANCER RESEARCH

IF10.2

2023-04-25

OAAI

Wethington, Stephanie L.; Shah, Payal D.; Martin, Lainie; Tanyi, Janos L.; Latif, Nawar; Morgan, Mark; Torigian, Drew A.; Rodriguez, Diego; Smith, Simon A.; Dean, Emma; Domchek, Susan M.; Drapkin, Ronny; Shih, Ie-Ming; Brown, Eric J.; Hwang, Wei -Ting; Armstrong, Deborah K.; Gaillard, Stephanie; Giuntoli, Robert; Simpkins, Fiona

[18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-inhibitor drug-target engagement as a biomarker of response in ovarian cancer [18F]FluorThanatrace ([18F]FTT) PARP抑制剂药物靶向参与的PET成像作为卵巢癌反应的生物标志物

CANCER RESEARCH

IF16.6

2023-04-04

PREAI

Gitto, Sarah B.; Pantel, Austin R.; Makvandi, Mehran; Kim, Hyoung; Medvedev, Sergey; Weeks, Joanna K.; Torigian, Drew A.; Hsieh, Chia-Ju; Ferman, Benjamin; Latif, Nawar A.; Tanyi, Janos L.; Martin, Lainie P.; Lanzo, Shannon M.; Liu, Fang; Cao, Quy; Mills, Gordon B.; Doot, Robert K.; Mankoff, David A.; Mach, Robert H.; Lin, Lilie L.; Simpkins, Fiona

FIRST-IN-HUMAN PHASE I CLINICAL TRIAL EVALUATING INTRAPERITONEAL ADMINISTRATION OF MOV19-BBZ CAR T CELLS IN PATIENTS WITH ALPHA FOLATE RECEPTOR-EXPRESSING RECURRENT HIGH GRADE SEROUS OVARIAN CANCER

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2021-11-10

OAAI

Shah, Payal; Shlanksy-Goldberg, Richard; Martin, Lainie; Nadolski, Gregory; Hexner, Elizabeth; Shamimi-Noori, Susan; Hwang, Wei-Ting; Matlawski, Tina; Cervini, Amanda; Shea, Joanne; Nelson, Lauren; Lacey, Simon; Plesa, Gabriela; Lledo, Lester; Dengel, Karen; Marshall, Amy; Leskowitz, Rachel; Kandalaft, Lana; Figini, Mariangela; Canevari, Silvana; Coukos, George; Powell, Daniel

Sources of Palliative Care Knowledge Among Patients With Advanced or Metastatic Gynecologic Cancer 晚期或转移性妇科癌症患者的姑息治疗知识来源

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

IF3.5

2021-03-01

OAAI

Hicks-Courant, Katherine; Graul, Ashley; Ko, Emily; Giuntoli, Robert; Martin, Lainie; Morgan, Mark; Haggerty, Ashley

Ovarian Cancer, Version 2.2020

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2021-02-01

447

OAAI

Armstrong, Deborah K.; Alvarez, Ronald D.; Bakkum-Gamez, Jamie N.; Barroilhet, Lisa; Behbakht, Kian; Berchuck, Andrew; Chen, Lee-may; Cristea, Mihaela; DeRosa, Maria; Eisenhauer, Eric L.; Gershenson, David M.; Gray, Heidi J.; Grisham, Rachel; Hakam, Ardeshir; Jain, Angela; Karam, Amer; Konecny, Gottfried E.; Leath, Charles A., III; Liu, Joyce; Mahdi, Haider; Martin, Lainie; Matei, Daniela; McHale, Michael; McLean, Karen; Miller, David S.; O'Malley, David M.; Percac-Lima, Sanja; Ratner, Elena; Remmenga, Steven W.; Vargas, Roberto; Werner, Theresa L.; Zsiros, Emese; Burns, Jennifer L.; Engh, Anita M.

Mirvetuximab soravtansine (MIRV), a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with carboplatin (CARBO) and bevacizumab (BEV): Final results from a study in patients (pts) with recurrent platinum sensitive ovarian cancer

ANNALS OF ONCOLOGY

IF65.4

2020-09-01

OAAI

O'Malley, D. M.; Richardson, D. L.; Vergote, I. B.; Gilbert, L.; Castro, C.; Provencher, D.; Matulonis, U. A.; Mantia-Smaldone, G.; Martin, L.; Zweidler-Mckay, P. A.; Moore, K. N.

A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer mirvetuximab soravtansine治疗铂类耐药卵巢癌的研究进展

FUTURE ONCOLOGY

IF2.6

2017-11-03

OAAI

Moore, Kathleen N.; Martin, Lainie P.; O'Malley, David M.; Matulonis, Ursula A.; Konner, Jason A.; Vergote, Ignace; Ponte, Jose F.; Birrer, Michael J.

Distress and Financial Distress in Adults With Cancer: An Age-Based Analysis

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2017-10-05

OAAI

Meeker, Caitlin R.; Wong, Yu-Ning; Egleston, Brian L.; Hall, Michael J.; Plimack, Elizabeth R.; Martin, Lainie P.; von Mehren, Margaret; Lewis, Bianca R.; Geynisman, Daniel M.

Ovarian Cancer, Version 1.2016

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2016-09-01

252

OAAI

Morgan, Robert J., Jr.; Armstrong, Deborah K.; Alvarez, Ronald D.; Bakkum-Gamez, Jamie N.; Behbakht, Kian; Chen, Lee-May; Copeland, Larry; Crispens, Marta Ann; DeRosa, Maria; Dorigo, Oliver; Gershenson, David M.; Gray, Heidi J.; Hakam, Ardeshir; Havrilesky, Laura J.; Johnston, Carolyn; Lele, Shashikant; Martin, Lainie; Matulonis, Ursula A.; O'Malley, David M.; Penson, Richard T.; Percac-Lima, Sanja; Pineda, Mario; Plaxe, Steven C.; Powell, Matthew A.; Ratner, Elena; Remmenga, Steven W.; Rose, Peter G.; Sabbatini, Paul; Santoso, Joseph T.; Werner, Theresa L.; Burns, Jennifer; Hughes, Miranda

First-in-human study of AMG 820, a monoclonal anti-CSF-1R (c-fms) antibody, in patients (pts) with advanced solid tumors

CANCER RESEARCH

IF16.6

2016-07-15

PREAI

Papadopoulos, Kyriakos; Gluck, Larry; Martin, Lainie P.; Olszanski, Anthony J.; Ngarmchamnanrith, Gateree; Rasmussen, Erik; Amore, Benny; Nagorsen, Dirk; Hill, John S.; Stephenson, Joe

Weekly Versus Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer

OBSTETRICAL & GYNECOLOGICAL SURVEY

IF3.6

2016-06-01

PREAI

Chan, John K.; Brady, Mark F.; Penson, Richard T.; Huang, Helen; Birrer, Michael J.; Walker, Joan L.; DiSilvestro, Paul A.; Rubin, Stephen C.; Martin, Lainie P.; Davidson, Susan A.; Huh, Warner K.; O'Malley, David M.; Boente, Matthew P.; Michael, Helen; Monk, Bradley J.

研究方向